Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Knockdown of EGFR inhibits growth and invasion of gastric cancer cells

Cancer Gene Therapy volume 21, pages 491–497 (2014)Cite this article

Subjects

Abstract

The epidermal growth factor receptor (EGFR) is an oncogenic trans-membranous receptor, which is overexpressed in multiple human cancers. However, the role of EGFR in gastric cancer (GC) is still elusive. In this study, we aimed to investigate the expression and molecular mechanisms of EGFR in GC cells. Forty cases of GC and the corresponding adjacent non-cancerous tissues (ANCT) were collected, and the expression of EGFR was assessed using immunohistochemistry in biopsy samples. Furthermore, EGFR signaling was blocked by constructed recombinant small hairpin RNA lentiviral vector (Lv-shRAGE) used to transfect into human GC SGC-7901 cells. The expression of AKT, proliferating cell nuclear antigen (PCNA) and matrix metallopeptidase-9 (MMP-9) was detected by real-time PCR and western blotting assays. Cell proliferative activities and invasive capability were, respectively, determined by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) and Transwell assays. Cell apoptosis and cycle distribution were analyzed by flow cytometry. EGFR was found highly expressed in cancer tissues compared with the ANCT and correlated with lymph node metastases. Knockdown of EGFR reduced cell proliferation and invasion of GC with decreased expression of AKT, PCNA and MMP-9 and induced cell apoptosis and cycle arrest. Upregulation of EGFR expression is associated with lymph node metastases of GC, and blockade of EGFR signaling suppresses growth and invasion of GC cells through AKT pathway, suggesting that EGFR may represent a potential therapeutic target for this aggressive malignancy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Luo HQ, Han L, Jiang Y . Meta-analysis of six randomized control trials of chemotherapy plus anti-HER monoclonal antibody for advanced gastric and gastroesophageal cancer. Asian Pac J Cancer Prev 2014; 15 (13): 5343–5348.

    Article  PubMed  Google Scholar 

  2. Lyu X, Huang J, Liu J, Wang W, Su Y, Zhang W et al. Detection and significance of epidermal growth factor receptor mutation in esophageal, esophagogastric junction and gastric cancers. Zhonghua Zhong Liu Za Zhi 2014; 36 (5): 346–350 Chinese.

    PubMed  Google Scholar 

  3. Li Y, Tan BB, Zhao Q, Fan LQ, Wang D, Liu Y . ZNF139 promotes tumor metastasis by increasing migration and invasion in human gastric cancer cells. Neoplasma 2014; 61 (3): 291–298.

    Article  CAS  PubMed  Google Scholar 

  4. Liu G, Jiang C, Li D, Wang R, Wang W . MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer. Tumour Biol 2014: 36–45.

  5. Smyth EC, Sclafani F, Cunningham D . Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors. Onco Targets Ther 2014; 7: 1001–1014.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Rolfo C, Bronte G, Sortino G, Papadimitriou K, Passiglia F, Fiorentino E et al. The role of targeted therapy for gastrointestinal tumors. Expert Rev Gastroenterol Hepatol 2014; 7: 1–11.

    Google Scholar 

  7. Guan SS, Chang J, Cheng CC, Luo TY, Ho AS, Wang CC et al. Afatinib and its encapsulated polymeric micelles inhibits HER2-overexpressed colorectal tumor cell growth in vitro and in vivo. Oncotarget 2014; 5 (13): 4868–4880.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Luo BH, Xiong F, Wang JP, Li JH, Zhong M, Liu QL et al. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells. PLoS One 2014; 9: 332–343.

    Google Scholar 

  9. Vaiopoulos AG, Kostakis ID, Gkioka E, Athanasoula KCh, Pikoulis E, Papalambros A et al. Detection of circulating tumor cells in colorectal and gastric cancer using a multiplex PCR assay. Anticancer Res 2014; 34 (6): 3083–3092.

    CAS  PubMed  Google Scholar 

  10. Choi MR, An CH, Chung YJ, Choi YJ, Yoo NJ, Lee SH . Mutational and expressional analysis of ERBB3 gene in common solid cancers. APMIS 2014; 23: 113–124.

    Google Scholar 

  11. Musiani D, Konda JD, Pavan S, Torchiaro E, Sassi F, Noghero A et al. Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy. FASEB J 2014; 23: 456–468.

    Google Scholar 

  12. Xu L, Qu X, Li H, Li C, Liu J, Zheng H et al. Src/caveolin-1-regulated EGFR activation antagonizes TRAIL-induced apoptosis ingastric cancer cells. Oncol Rep 2014; 32 (1): 318–324.

    Article  CAS  PubMed  Google Scholar 

  13. Aprile G, Giampieri R, Bonotto M, Bittoni A, Ongaro E, Cardellino GG et al. The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey. Expert Opin Investig Drugs 2014; 23 (7): 925–942.

    Article  CAS  PubMed  Google Scholar 

  14. Kurokawa Y, Matsuura N, Kawabata R, Nishikawa K, Ebisui C, Yokoyama Y et al. Prognostic impact of major receptor tyrosine kinase expression in gastric cancer. Ann Surg Oncol 2014; 11: 432–441.

    Google Scholar 

  15. Nielsen TO, Friis-Hansen L, Poulsen SS, Federspiel B, Sorensen BS . Expression of the EGF family in gastric cancer: downregulation of HER4 and its activating ligand NRG4. PLoS One 2014; 9 (4): e94606.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Wei J, Zhao ZX, Li Y, Zhou ZQ, You TG . Cortactin expression confers a more malignant phenotype to gastric cancer SGC-7901 cells. World J Gastroenterol 2014; 20 (12): 3287–3300.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zhang EB, Kong R, Yin DD, You LH, Sun M, Han L et al. Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a. Oncotarget 2014; 5 (8): 2276–2292.

    PubMed  PubMed Central  Google Scholar 

  18. Yan M, Parker BA, Schwab R, Kurzrock R . HER2 aberrations in cancer: implications for therapy. Cancer Treat Rev 2014; 40 (6): 770–780.

    Article  CAS  PubMed  Google Scholar 

  19. Naruke A, Azuma M, Takeuchi A, Ishido K, Katada C, Sasaki T et al. Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer. Gastric Cancer 2014; 9: 116–124.

    Google Scholar 

  20. Jiang L, Chen Y, Sang J, Li Y, Lan T, Wang Y et al. Type II cGMP-dependent protein kinase inhibits activation of key members of the RTK family in gastric cancer cells. Biomed Rep 2013; 1 (3): 399–404.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Nagatsuma AK, Aizawa M, Kuwata T, Doi T, Ohtsu A, Fujii H et al. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma. Gastric Cancer 2014; 14: 783–797.

    Google Scholar 

  22. Zhang J, Cao J, Li J, Zhang Y, Chen Z, Peng W et al. A phase I study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors. J Hematol Oncol 2014; 7: 22.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ye B, Jiang LL, Xu HT, Zhou DW, Li ZS . Expression of PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis. Int J Immunopathol Pharmacol 2012; 25: 627–636.

    Article  CAS  PubMed  Google Scholar 

  24. Xie J, Chen M, Zhou J, Mo MS, Zhu LH, Liu YP et al. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression. Oncol Rep 2014; 31 (4): 1715–1722.

    Article  CAS  PubMed  Google Scholar 

  25. Jiang L, Chen Y, Li Y, Lan T, Wu M, Wang Y et al. Type II cGMP-dependent protein kinase inhibits ligand-induced activation of EGFR ingastric cancer cells. Mol Med Rep 2014; 9 (4): 1405–1409.

    Article  CAS  PubMed  Google Scholar 

  26. Chaturvedi R, Asim M, Piazuelo MB, Yan F, Barry DP, Sierra JC et al. Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastricepithelial cells with DNA damage. Gastroenterology 2014 146 7: 1739.e14–1751.e14.

    Google Scholar 

  27. Gala K, Chandarlapaty S . Molecular pathways: HER3 targeted therapy. Clin Cancer Res 2014; 20 (6): 1410–1416.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Agaimy A, Rau TT, Hartmann A, Stoehr R . SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review. Am J Surg Pathol 2014; 38 (7): 910–920.

    Article  PubMed  Google Scholar 

  29. Tajiri R, Ooi A, Fujimura T, Dobashi Y, Oyama T, Nakamura R et al. Intratumoral heterogeneous amplification of ERBB2 and subclonal genetic diversity in gastric cancers revealed by multiple ligation-dependent probe amplification and fluorescence in situ hybridization. Hum Pathol 2014; 45 (4): 725–734.

    Article  CAS  PubMed  Google Scholar 

  30. Shi M, Shi H, Ji J, Cai Q, Chen X, Yu Y et al. Cetuximab inhibits gastric cancer growth in vivo, independent of KRAS status. Curr Cancer Drug Targets 2014; 16: 763–784.

    Google Scholar 

  31. Terragni R, Casadei Gardini A, Sabattini S, Bettini G, Amadori D, Talamonti C et al. EGFR, HER-2 and KRAS in canine gastric epithelial tumors: a potential human model? PLoS One 2014; 9 (1): e85388.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Zhang J, Zhan Z, Wu J, Zhang C, Yang Y, Tong S et al. Relationship between EGF, TGFA, and EGFR gene polymorphisms and traditional Chinese medicine ZHENG in gastric cancer. Evid Based Complement Alternat Med 2013; 2013: 731071.

    PubMed  PubMed Central  Google Scholar 

  33. Zhang L, Zhao G, Hou Y, Zhang J, Hu J, Zhang K . The experimental study on the treatment of cytokine-induced killer cells combined with EGFR monoclonal antibody against gastric cancer. Cancer Biother Radiopharm 2014; 29 (3): 99–107.

    Article  CAS  PubMed  Google Scholar 

  34. Hong L, Han Y, Brain L . The role of epidermal growth factor receptor in prognosis and treatment of gastric cancer. Expert Rev Gastroenterol Hepatol 2014; 8 (1): 111–117.

    Article  CAS  PubMed  Google Scholar 

  35. Feng D, Ma Y, Liu J, Xu L, Zhang Y, Qu J et al. Cbl-b enhances sensitivity to 5-fluorouracil via EGFR- and mitochondria-mediated pathways in gastric cancer cells. Int J Mol Sci 2013; 14 (12): 24399–24411.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Zhang EB, Han L, Yin DD, Kong R, De W, Chen J . c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer. Med Oncol 2014; 31 (5): 914.

    Article  PubMed  Google Scholar 

  37. Aydin K, Okutur SK, Bozkurt M, Turkmen I, Namal E, Pilanci K et al. Effect of epidermal growth factor receptor status on the outcomes of patients with metastatic gastric cancer: a pilot study. Oncol Lett 2014; 7 (1): 255–259.

    Article  CAS  PubMed  Google Scholar 

  38. Ito A, Ito Y, Matsushima S, Tsuchida D, Ogasawara M, Hasegawa J et al. New whole-body multimodality imaging of gastric cancer peritoneal metastasis combining fluorescence imaging with ICG-labeled antibody and MRI in mice. Gastric Cancer 2014; 17 (3): 497–507.

    Article  CAS  PubMed  Google Scholar 

  39. Pang Q, Ge J, Shao Y, Sun W, Song H, Xia T et al. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumour Biol 2014; 35 (6): 5441–5447.

    Article  CAS  PubMed  Google Scholar 

  40. Wang Y, Feng X, Jia R, Liu G, Zhang M, Fan D et al. Microarray expression profile analysis of long non-coding RNAs of advanced stage human gastric cardia adenocarcinoma. Mol Genet Genomics 2014; 289 (3): 291–302.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterological Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    Y Zhen, L Guanghui & Z Xiefu

Authors
  1. Y Zhen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L Guanghui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Z Xiefu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Z Xiefu.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhen, Y., Guanghui, L. & Xiefu, Z. Knockdown of EGFR inhibits growth and invasion of gastric cancer cells. Cancer Gene Ther 21, 491–497 (2014). https://doi.org/10.1038/cgt.2014.55

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2014.55

This article is cited by

Search

Advanced search

Quick links